Mahmoud Mohammadi

4PUBLICATIONS
5CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 20, 2023
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data.

Mahmoud Mohammadi, Nikki S IJzerman, Dide den Hollander

|Nov 14, 2022
Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients.

Mahmoud Mohammadi, Thekla M Jansen-Werkhoven, Nikki S Ijzerman

|Nov 30, 2020
Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib.

Mahmoud Mohammadi, Hans Gelderblom

|Apr 05, 2020
Gastrointestinal Stromal Tumours (GIST) in Young Adult (18-40 Years) Patients: A Report from the Dutch GIST Registry.

Nikki S IJzerman, Cas Drabbe, Dide den Hollander

Pageof 1

Frequent Collaborators

2 joint publications

Hans Gelderblom

1 joint publications

Nikki S IJzerman

1 joint publications

Dide den Hollander

1 joint publications

Max M van Noesel